Sign in

NCT04529707Completed

Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy

Sleep Health Dysfunction and the Use of a Transdiagnostic Sleep Intervention in Duchenne Muscular Dystrophy

Source: ClinicalTrials.gov · Last updated 7 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This project will systematically plan and evaluate the implementation of the Transdiagnostic Sleep and Circadian Intervention for youth (TranS-CY). As an early stage study, investigators will focus on recruitment strategies to reach the target population and collection of preliminary data on primary and secondary effects of the TranS-CY. Weekly remote (video web conferencing) parent training sessions will allow investigators to explore adoption through parent adherence and examine whether the essential elements of the TranS-CY intervention (e.g., motivational interviewing, goal setting, problem solving, sleep routine scheduling, monitoring) can be consistently taught by clinicians and implemented by parents into the home setting.

Status (registry)
Completed
Study type
Interventional
Enrollment
38 (actual)
First submitted
17 Aug 2020
Start date
17 Feb 2021
Primary completion date
31 Oct 2024
Lead sponsor
University of Pittsburgh
NCT number
NCT04529707

What you commit to

  • Study type: Interventional
  • Participants enrolled: 38
  • From 17 Feb 2021 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Their child/youth with DMD is currently receiving an intervention for a sleep related disorder

Other

  • Unable to speak or read English
  • Their child with DMD has cognitive or behavioral concerns that would limit participation and follow-through of intervention;

Who the study is looking for

  • Parents/caregivers of youth between ages 6 and 17 with a primary diagnosis of Duchenne muscular dystrophy (DMD) who lives at home .
  • Access to a smart-phone or computer and internet for the weekly web-based sessions, as well as uploading of the Actigraph data;
  • English speaking.

Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.